BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19148138)

  • 21. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
    Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
    Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Submicroscopic deletions of immunoglobulin heavy chain gene (IGH) in precursor B lymphoblastic leukemia with IGH rearrangements.
    Huh J; Mun YC; Yoo ES; Seong CM; Chung WS
    Ann Lab Med; 2015 Jan; 35(1):128-31. PubMed ID: 25553293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of novel, recurrent genomic rearrangements as sensitive MRD targets in childhood B-cell precursor ALL.
    Zur Stadt U; Alawi M; Adao M; Indenbirken D; Escherich G; Horstmann MA
    Blood Cancer J; 2019 Nov; 9(12):96. PubMed ID: 31784504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene].
    Matolcsy A; Borbényi Z; Demeter J; Egyed M; Fekete S; Földi J; Gergely L; Kajtár P; Kelényi G; Kiss A; László T; Lehoczky D; Losonczy H; Nagy M; Pál K; Pálóczy K; Radványi G; Semsei I; Varga G; Udvardy M
    Orv Hetil; 2000 Jun; 141(25):1403-6. PubMed ID: 10934884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-125b-1 and BLID upregulation resulting from a novel IGH translocation in childhood B-Cell precursor acute lymphoblastic leukemia.
    Tassano E; Acquila M; Tavella E; Micalizzi C; Panarello C; Morerio C
    Genes Chromosomes Cancer; 2010 Aug; 49(8):682-7. PubMed ID: 20544842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of clonality with immunoglobulin heavy chain gene rearrangement fingerprinting map in childhood acute lymphoblastic leukemia].
    Liu J; Lu S; Zhu P; Xue H
    Zhonghua Xue Ye Xue Za Zhi; 1997 Jan; 18(1):21-4. PubMed ID: 15622745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shared clonal IGH rearrangement in BCP-ALL occurring after CLL: pitfalls and implications for MRD monitoring.
    Derrieux C; Gish A; Caulier A; Grardel N; Garidi R; Joris M; Assouan D; Poulain S; Decool G; Ferret Y; Caillault-Venet A; Marolleau JP; Preudhomme C; Boyer T
    Br J Haematol; 2020 Nov; 191(3):506-509. PubMed ID: 32754904
    [No Abstract]   [Full Text] [Related]  

  • 28. Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.
    Herold T; Schneider S; Metzeler KH; Neumann M; Hartmann L; Roberts KG; Konstandin NP; Greif PA; Bräundl K; Ksienzyk B; Huk N; Schneider I; Zellmeier E; Jurinovic V; Mansmann U; Hiddemann W; Mullighan CG; Bohlander SK; Spiekermann K; Hoelzer D; Brüggemann M; Baldus CD; Dreyling M; Gökbuget N
    Haematologica; 2017 Jan; 102(1):130-138. PubMed ID: 27561722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgH/TCR delta PCR oligonucleotide liquid hybridization, a fast and sensitive assay for monitoring minimal residual disease in childhood B-precursor ALL.
    Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; von dem Borne AE; van der Schoot CE
    Leukemia; 1995 Jan; 9(1):216-22. PubMed ID: 7845021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nondisjunction of chromosomes leading to hyperdiploid childhood B-cell precursor acute lymphoblastic leukemia is an early event during leukemogenesis.
    Panzer-Grümayer ER; Fasching K; Panzer S; Hettinger K; Schmitt K; Stöckler-Ipsiroglu S; Haas OA
    Blood; 2002 Jul; 100(1):347-9. PubMed ID: 12070048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double CEBPE-IGH rearrangement due to chromosome duplication and cryptic insertion in an adult with B-cell acute lymphoblastic leukemia.
    Pierini V; Nofrini V; La Starza R; Barba G; Vitale A; Di Raimondo F; Matteucci C; Crescenzi B; Elia L; Gorello P; Storlazzi CT; Mecucci C
    Cancer Genet; 2011 Oct; 204(10):563-8. PubMed ID: 22137487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia.
    Chapiro E; Russell LJ; Struski S; Cavé H; Radford-Weiss I; Valle VD; Lachenaud J; Brousset P; Bernard OA; Harrison CJ; Nguyen-Khac F
    Leukemia; 2010 Jul; 24(7):1362-4. PubMed ID: 20485370
    [No Abstract]   [Full Text] [Related]  

  • 33. Considerations for monitoring minimal residual disease using immunoglobulin clonality in patients with precursor B-cell lymphoblastic leukemia.
    Jo I; Chung NG; Lee S; Kwon A; Kim J; Choi H; Jang W; Kim S; Lee JW; Yoon JH; Cho B; Han K; Kim Y; Kim M
    Clin Chim Acta; 2019 Jan; 488():81-89. PubMed ID: 30389459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
    Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
    Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients.
    Toubai T; Tanaka J; Ota S; Fukuhara T; Hashino S; Kondo T; Kasai M; Kakinoki Y; Masauzi N; Morioka M; Kawamura T; Iwasaki H; Asaka M; Imamura M
    Am J Hematol; 2005 Nov; 80(3):181-7. PubMed ID: 16247752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of clonal stability of minimal residual disease targets between 1st and 2nd relapse of childhood precursor B-cell acute lymphoblastic leukemia.
    Guggemos A; Eckert C; Szczepanski T; Hanel C; Taube T; van der Velden VH; Graf-Einsiedel H; Henze G; Seeger K
    Haematologica; 2003 Jul; 88(7):737-46. PubMed ID: 12857551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia.
    Umiel T; Pattengale P; Weinberg K
    Leukemia; 1993 Mar; 7(3):435-40. PubMed ID: 8445948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying IGH disease clones for MRD monitoring in childhood B-cell acute lymphoblastic leukemia using RNA-Seq.
    Li Z; Jiang N; Lim EH; Chin WHN; Lu Y; Chiew KH; Kham SKY; Yang W; Quah TC; Lin HP; Tan AM; Ariffin H; Yang JJ; Yeoh AE
    Leukemia; 2020 Sep; 34(9):2418-2429. PubMed ID: 32099036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determining the repertoire of IGH gene rearrangements to develop molecular markers for minimal residual disease in B-lineage acute lymphoblastic leukemia.
    Brisco MJ; Latham S; Sutton R; Hughes E; Wilczek V; van Zanten K; Budgen B; Bahar AY; Malec M; Sykes PJ; Kuss BJ; Waters K; Venn NC; Giles JE; Haber M; Norris MD; Marshall GM; Morley AA
    J Mol Diagn; 2009 May; 11(3):194-200. PubMed ID: 19324994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapse.
    van der Velden VH; Brüggemann M; Hoogeveen PG; de Bie M; Hart PG; Raff T; Pfeifer H; Lüschen S; Szczepański T; van Wering ER; Kneba M; van Dongen JJ
    Leukemia; 2004 Dec; 18(12):1971-80. PubMed ID: 15470492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.